Clinical Trials Logo

Recurrence clinical trials

View clinical trials related to Recurrence.

Filter by:

NCT ID: NCT06061068 Recruiting - Quality of Life Clinical Trials

Hernia Belt in Laparoscopic Inguinal Hernia Repair

Start date: July 17, 2023
Phase: N/A
Study type: Interventional

In this study, the investigators aimed to investigate the effect of hernia belt on postoperative complications and quality of life for patients who underwent laparoscopic inguinal hernia repair. Outcomes include hernia recurrence (patient-reported and clinical exam), postoperative complications within 3 months (seroma and hematoma development, wound infection, abdominal bloating and foreign body sensation), pain (visual analog scale,VAS), health-related quality of life (36-item short-form health survey, SF-36). Follow up by physical examination, ultrasonography and telephone.

NCT ID: NCT06060002 Not yet recruiting - Choledocholithiasis Clinical Trials

Role of Prophylactic Biliary Stent in Reducing the Recurrence of Choledocholithiasis

STONE
Start date: September 30, 2023
Phase: N/A
Study type: Interventional

We planned this multicenter randomized controlled trial to study the role of a prophylactic biliary stent in recurrence of stones and biliary complications in patients awaiting cholecystectomy after biliary stone clearance

NCT ID: NCT06059625 Completed - Clinical trials for Cuff Injury, Rotator

RECURRENCE OF ROTATOR CUFF LESION AFTER SURGICAL REPAIR WITH SINGLE-ROW vs DOUBLE-ROW SUTURE BRIDGE TECNIQUE: A COMPARATIVE STUDY

Start date: April 14, 2021
Phase: N/A
Study type: Interventional

The rotator cuff is a muscle-tendon complex consisting of the tendons of the supraspinatus, subspinatus, subscapularis, and small round muscles capable of allowing movement of the shoulder joint in the various planes of space and stabilizing the glenohumeral joint. Rotator cuff tendon injuries are very common. In most cases, these injuries are mostly degenerative based, as they are related to the aging process of the individual. However, it is increasingly common to diagnose such injuries in young individuals as well. The reported incidence of rotator cuff injuries ranges from 5% to 40%, and of course the prevalence increases with age until it reaches 51% in patients older than 80 years. The diagnosis of rotator cuff injury is made based on clinical examination and instrumental investigations such as Nuclear Magnetic Resonance Imaging (MRI). Rotator cuff repair involves the use of anchors with included suture threads that allow the tendons to be returned to the level of the anatomical insertion, called the footprint. Suture technique varies depending on the extent of injury and tendon and bone quality. Single-row (single row) or double-row suture bridge (double-row suture bridge) anchoring techniques are currently a hotly debated topic in the literature.

NCT ID: NCT06052839 Recruiting - Clinical trials for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC

Start date: October 3, 2023
Phase: Phase 2
Study type: Interventional

The rationale for the new sequence of pulsed dose chemotherapy proposed in this trial is based on the hypotheses that current standard dosing of chemotherapy plus pembrolizumab ultimately suppresses the immune system and has a negative effect on the efficacy of the anti-PD-1 monoclonal antibody (mAb) therapy and that chemotherapy given after anti-PD-1 mAb therapy is associated with higher efficacy.

NCT ID: NCT06050538 Completed - Clinical trials for Recurrent Inguinal Hernia

Laparscopic Hernioplasty in Recurrent Inguinal Hernia

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study was to compare between laparoscopic transabdominal preperitoneal (TAPP) and totally extraperitoneal (TEP) repair of inguinal hernia in recurrent inguinal hernia.

NCT ID: NCT06050148 Recruiting - Clinical trials for Recurrent Urinary Tract Infection

Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections

FMT-UTI
Start date: August 1, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

This study investigates Faecal microbiota transplantation (FMT) in prevention of recurrent urinary tract infections (UTIs) caused either by sensitive E. coli or ESBL-E. coli.

NCT ID: NCT06046131 Recruiting - Neoplasm Metastasis Clinical Trials

Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.

KP-CARAIBES
Start date: February 28, 2023
Phase: N/A
Study type: Interventional

The course and progression of prostate cancer is highly variable, depending on the individual characteristics, the aggressiveness of the disease at the time of diagnosis as well as the ethno-geographic origins of the individuals. The general objective of the project is to identify the clinical, genetic and environmental determinants (risk factors) of the evolution, progression and complications of the disease according to the treatment options. Identifying modifiable and non-modifiable prognostic determinants of disease progression is a major challenge. This knowledge will help guide treatment choices but also, especially in high-risk populations (high incidence of disease) to better tailor prevention policies and possibly screening .

NCT ID: NCT06039774 Recruiting - Clinical trials for Recurrent Aphthous Stomatitis

α-Mangostin Hydrogel Film With Chitosan Alginate Base for Recurrent Aphthous Stomatitis (RAS)

AM-RAS
Start date: December 4, 2023
Phase: Phase 2
Study type: Interventional

Recurrent Aphthous Stomatitis (RAS) is experienced by almost everyone and appears suddenly. Even though the risk of death due to the condition is small, its presence can make a person feel uncomfortable eating, drinking, and talking so there will be a decrease in the quality of a person's life in their daily lives. Recently, α-Mangostin (α-M) from mangosteen rind (Garcinia mangostana L) has been shown its effect to reduce oral mucosal sores on RAS in preclinical studies in rats. Therefore, research is needed to prove the benefits (efficacy) and safety of therapy in the form of a hydrogel film patch/plaster film with a chitosan alginate base as a carrier for α-Mangostin for the treatment of RAS patients.

NCT ID: NCT06039709 Recruiting - Clinical trials for Glioblastoma Multiforme

Sonodynamic Therapy in Patients With Recurrent GBM

GBM 001
Start date: January 31, 2024
Phase: Phase 1
Study type: Interventional

Patients diagnosed with glioblastoma (GBM) are faced with limited treatment options. This pilot study will evaluate the safety and feasibility of combining an investigational drug called 5-ALA with neuronavigation-guided low-intensity focused ultrasound (LIFU) for patients who have recurrent GBM. Focused ultrasound (FUS) can be used to non-invasively destroy tumor tissue while preserving normal tissue. When FUS is combined with 5-ALA, this combinatorial approach is called sonodynamic therapy (SDT), and this investigational therapy is being tested for its ability to cause damage to GBM cells. SDT will take place prior to surgery for recurrent GBM.

NCT ID: NCT06038422 Not yet recruiting - Recurrence Clinical Trials

GTP Regimen in the Treatment of Refractory/Recurrent HLH

Start date: September 15, 2023
Phase: Phase 3
Study type: Interventional

The goal of this clinical trial is to learn about efficacy and safety of GTP regimen in refractory/recurrent hemophagocytic lymphohistiocytosis. The main questions it aims to answer are: - Overall remission rate of GTP regimen in R/R HLH - Adverse effect of GTP regimen Participants will be treated with GTP regimen